Renovaro Biosciences Inc. (NASDAQ: RENB)
$1.41
+0.0100 ( +0.71% ) 143.7K
Renovaro Inc formerly Renovaro Biosciences Inc is a biopharmaceutical company. It is engaged in the research and development of pharmaceutical and biological products for the treatment of HIV, HBV, and cancer with the intent to manufacture said products.
Market Data
Open
$1.41
Previous close
$1.40
Volume
143.7K
Market cap
$218.58M
Day range
$1.39 - $1.45
52 week range
$0.66 - $5.25
SEC Fillings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 13 | Oct 02, 2023 |
| 10-k | Annual reports | 97 | Oct 02, 2023 |
| 8-k | 8K-related | 14 | Sep 29, 2023 |
| nt | Quarterly Reports | 1 | Sep 29, 2023 |
| 4 | Insider transactions | 1 | Sep 12, 2023 |
| 8-k | 8K-related | 13 | Aug 09, 2023 |
| 8-k | 8K-related | 24 | Aug 07, 2023 |
| 8-k | 8K-related | 15 | Aug 07, 2023 |
| 4 | Insider transactions | 1 | Aug 01, 2023 |
| 8-k | 8K-related | 12 | Jul 28, 2023 |